Stock PINC PREMIER, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Premier, Inc.

Equities

PINC

US74051N1028

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
18.92 USD +1.01% Intraday chart for Premier, Inc. -0.37% -15.38%
May. 29 Premier Insider Sold Shares Worth $253,042, According to a Recent SEC Filing MT
May. 28 JPMorgan Adjusts Price Target on Premier to $21 From $23, Maintains Neutral Rating MT

Valuation

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,418 2,454 4,254 4,210 3,294 1,983 - -
Enterprise Value (EV) 1 2,311 2,438 4,603 4,578 3,622 2,217 2,093 1,994
P/E ratio 21.6 x 5.26 x 15.7 x 16.3 x 18.8 x 23.5 x 11.1 x 10.1 x
Yield - - 2.18% 2.24% 3.04% 4.58% 4.73% 5.03%
Capitalization / Revenue 1.99 x 1.89 x 2.47 x 2.94 x 2.47 x 1.51 x 1.58 x 1.54 x
EV / Revenue 1.9 x 1.88 x 2.67 x 3.19 x 2.71 x 1.69 x 1.67 x 1.55 x
EV / EBITDA 4.12 x 4.32 x 9.73 x 9.18 x 7.25 x 5.27 x 5.63 x 5.21 x
EV / FCF 5.61 x 9.56 x 14.5 x 12.8 x 10 x 8.97 x 7.07 x 7.87 x
FCF Yield 17.8% 10.5% 6.92% 7.79% 10% 11.2% 14.2% 12.7%
Price to Book -5.74 x 30 x 1.91 x 1.77 x 1.42 x 1.03 x 0.93 x 0.86 x
Nbr of stocks (in thousands) 61,827 71,574 122,269 117,987 119,078 104,820 - -
Reference price 2 39.11 34.28 34.79 35.68 27.66 18.92 18.92 18.92
Announcement Date 8/20/19 8/25/20 8/17/21 8/16/22 8/22/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,218 1,300 1,721 1,433 1,336 1,313 1,254 1,286
EBITDA 1 561 564 473.2 498.7 499.8 420.6 372 382.7
EBIT 1 368.5 373.6 256.9 260.1 242.1 142.7 217.7 213.9
Operating Margin 30.26% 28.75% 14.93% 18.15% 18.12% 10.87% 17.36% 16.63%
Earnings before Tax (EBT) 1 368.1 383.7 250.6 326.9 250 108.7 226.9 250.7
Net income 1 109.1 436.8 260.8 265.9 175 89.96 150.5 157.3
Net margin 8.96% 33.61% 15.15% 18.55% 13.1% 6.85% 12% 12.23%
EPS 2 1.810 6.516 2.220 2.190 1.470 0.8060 1.710 1.865
Free Cash Flow 1 412 255.1 318.5 356.8 362.2 247.2 296.2 253.5
FCF margin 33.83% 19.63% 18.51% 24.9% 27.11% 18.83% 23.62% 19.71%
FCF Conversion (EBITDA) 73.43% 45.23% 67.31% 71.55% 72.48% 58.77% 79.63% 66.23%
FCF Conversion (Net income) 377.52% 58.41% 122.12% 134.2% 206.96% 274.77% 196.81% 161.12%
Dividend per Share 2 - - 0.7600 0.8000 0.8400 0.8673 0.8953 0.9512
Announcement Date 8/20/19 8/25/20 8/17/21 8/16/22 8/22/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales 1 379.2 347.8 340.7 313.9 359.6 322.2 340.4 318.8 334.7 342.6 313.2 308.8 333.3 315.5 304.5
EBITDA 1 142 112.2 122.8 109.4 140.5 117.3 132.6 105.7 114.1 107.3 89.47 93.97 98.42 92.04 88.57
EBIT 1 77.96 56.82 53.01 58.51 88.17 62.57 32.85 58.97 65.69 -78.73 46.15 50.11 55.06 52.01 45.35
Operating Margin 20.56% 16.34% 15.56% 18.64% 24.52% 19.42% 9.65% 18.5% 19.62% -22.98% 14.73% 16.23% 16.52% 16.49% 14.9%
Earnings before Tax (EBT) 1 83.6 53.76 49.2 61.73 88.14 65.88 34.25 56.35 72.14 -64.83 44.95 55.76 61.22 58.23 51.67
Net income 1 75.54 38.42 29.9 42.72 64.05 46.8 21.46 44.76 54.3 -40.2 35.08 41.94 45.15 42.13 37.86
Net margin 19.92% 11.04% 8.78% 13.61% 17.81% 14.52% 6.31% 14.04% 16.22% -11.73% 11.2% 13.58% 13.55% 13.36% 12.44%
EPS 2 0.6200 0.3200 0.2500 0.3600 0.5400 0.3900 0.1800 0.3700 0.4500 -0.3600 0.3500 0.3975 0.4525 0.4450 0.4150
Dividend per Share 2 0.2000 0.2000 0.2000 0.2100 0.2100 0.2100 0.2100 - - 0.2100 0.2152 0.2258 0.2258 0.2258 0.2258
Announcement Date 2/1/22 5/3/22 8/16/22 11/1/22 2/7/23 5/2/23 8/22/23 11/7/23 2/5/24 5/7/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - 349 368 329 233 110 11
Net Cash position 1 107 15.1 - - - - - -
Leverage (Debt/EBITDA) - - 0.7384 x 0.7383 x 0.6576 x 0.5549 x 0.295 x 0.0287 x
Free Cash Flow 1 412 255 319 357 362 247 296 253
ROE (net income / shareholders' equity) 22.1% 19.1% 22% 13.5% 13.1% 11% 11% 11.2%
ROA (Net income/ Total Assets) 14.3% 12.2% 9.46% 8.8% 8.9% 7.49% 6.72% 6.62%
Assets 1 763.1 3,576 2,758 3,021 1,967 1,201 2,240 2,378
Book Value Per Share 2 -6.820 1.140 18.20 20.10 19.50 18.40 20.30 22.10
Cash Flow per Share 2 8.380 5.210 3.470 3.650 3.210 3.050 4.000 4.860
Capex 1 93.4 94.4 88.9 87.4 82.3 90.5 91.1 93.7
Capex / Sales 7.67% 7.26% 5.16% 6.1% 6.16% 6.9% 7.27% 7.29%
Announcement Date 8/20/19 8/25/20 8/17/21 8/16/22 8/22/23 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Premier, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
18.92 USD
Average target price
21.12 USD
Spread / Average Target
+11.65%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
PREMIER, INC. Stock Premier, Inc.
-15.38% 1.98B
ABBOTT LABORATORIES Stock Abbott Laboratories
-7.16% 178B
MEDTRONIC PLC Stock Medtronic plc
-1.23% 107B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.86% 67.04B
DEXCOM, INC. Stock DexCom, Inc.
-4.28% 47.23B
CENCORA, INC. Stock Cencora, Inc.
+10.32% 44.62B
HOYA CORPORATION Stock Hoya Corporation
+8.14% 42.5B
TERUMO CORPORATION Stock Terumo Corporation
+15.53% 25.22B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-5.88% 24.14B
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-5.38% 23.69B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. PINC Stock
  4. Financials Premier, Inc.